This article is more than 5 years old. Information may no longer be current.
Posterior chamber iris-claw IOL effective in eyes with insufficient capsule support
Click Here to Manage Email Alerts
Implantation of a posterior chamber iris-claw aphakic IOL in eyes without capsule support yielded positive visual outcomes and an acceptable safety profile, according to a study.
The retrospective analysis included 137 eyes of 126 patients implanted with an Artisan/Verisyse posterior chamber iris-claw IOL (Ophtec/Abbott Medical Optics). Mean follow-up was 5 months.
Preoperatively, mean logMAR corrected distance visual acuity was 0.65, mean spherical equivalent ranged from –6 D to +16 D, and mean IOP was 17.4 mm Hg.
Postoperatively, mean logMAR corrected distance visual acuity was 0.38; the improvement was statistically significant (P < .05). Corrected distance visual acuity improved more than two lines in 57 eyes (41.6%).
Mean postoperative spherical equivalent was 0 D. At final follow-up, postoperative spherical equivalent was within 2 D of emmetropia in 128 eyes (93.4%) and 1 D of emmetropia in 104 eyes (75.9%).
Mean postoperative IOP was 14.2 mm Hg; the reduction was statistically significant (P < .05).
Complications included slight temporary pupil ovalization, cystoid macular edema and lens disenclavation, the authors said.
Click Here to Manage Email Alerts